Arkolith/Insider Trading/RAPP/Form 4

Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$327K
Net Open-Market Flow
-$327K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Sell(S)7K$39.77$292K549K
Jun 29, 2026Sell(S)876$40.34$35K548K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-292519) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML